NAMA: SITTI HAJIJAH SOO

NIM : 105421105517
INTRODUCTION
preliminary
Diabetes mellitus (DM) is wrong
one global health problem in the world.
World Health Organization (WHO) (2014)
stated that 347 billion residents
the world of diabetes diabetes and in the year
2030 diabetes is predicted to be the cause
seventh major death in the world.Other research
also mention that dyslipidemia and
Platelet dysfunction is a factor
cardiovascular risk in type DM patients
1, See the magnitude of the risk of morbidity and
mortality due to cardiovascular disease,
then the use of drugs for prevention
cardiovascular disease has a role
important. According to one therapy guideline
DM published by American Diabetes
Association (ADA) in 2015, therapy
statin and antiplatelet are recommended
for primary and secondary prevention
cardiovascular disease in DM.3 patients
Several studies have shown
effectiveness of statin use in terms of
primary and secondary prevention of disease
cardiovascular in DM.8,9 Evidence patients
the same effectiveness in reducing
risk of cardiovascular disease in patients
DM is also found in use
antiplatelet, especially in use
low-dose aspirin.
METHOD
This research uses research methods
non-experimental done
cross-sectional. House
sick place where this research took place
is one type B hospital
this pain has a bed occupancy ratio
(BOR) of approximately 80.00%. total
patients who seek treatment at poly out patient homes
this pain is around 1000 people per day.
This hospital also serves participating patients
Social Security Organizing Agency (BPJS)
Health.
The population in this study is
outpatient DM patients treated in poly
hospital outpatient during period 1
month, which is November 12 to December 15
2014. DM patients are defined as patients
who gets a DM diagnosis based on
doctor's diagnosis as written on the data
medical records. Likewise for diagnosis
other diseases in this study are based
doctor's diagnosis written on the record data
medical patient. Patients who are participants
research is those who state
willingness to take part in research with
signed an informed consent sheet.
The exclusion criteria were DM patients
who experienced contraindications to
administration of drugs with statins,
antiplatelet, or antihypertensive.
taken is 72 people.
Retrieving data for each patient
done by interview method for
get data on patient name, age, type
sex, family history, social history,
and drugs used by patients.
In addition, researchers also made observations
the patient's medical record data and results
laboratory tests to obtain
disease history, blood pressure, profile
lipid, albuminuria, complete data usage
medicine and dosage. Data retrieval
with these two methods are mutually exclusive
complete patient data.
CONCLUSION
This study shows the use of drugs
for the prevention of cardiovascular disease
(antiplatelet, statins, and ACEIs or ARBs)
in patients with DM it is still not optimal. Thing
this is one of the important phenomena
need to be considered by health workers
because of the risk of cardiovascular disease
owned by DM patients. Besides that, p
this can open opportunities for pharmacists,
as one of the experts in the field of medicine,
in monitoring usage
drug in DM patients, in addition to use
medicine to control blood sugar levels.
Further research is needed
identify factors that influence
low use of antiplatelet, statins,
and appropriate antihypertension in patients
DM so that prevention strategies are complications
cardiovascular can be more effective.